JULIAN BAKER Insider Trading $IDRA IDERA PHARMACEUTICALS, INC.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for JULIAN BAKER.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of JULIAN BAKER. JULIAN BAKER is Director in INCYTE CORP ($INCY) and Director in IDERA PHARMACEUTICALS, INC. ($IDRA) and Director in XOMA Corp ($XOMA) and 10% Owner in SYNAGEVA BIOPHARMA CORP ($GEVA) and Director in SYNAGEVA BIOPHARMA CORP ($GEVA) and Director in GENOMIC HEALTH INC ($GHDX).
JULIAN BAKER in IDERA PHARMACEUTICALS, INC.
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of JULIAN BAKER: Director
Holdings: 6,323,855 shares
Current Value: $9,865,214
Latest Transaction: Feb 17 2015
$IDRA Market Capitalization: $230.34M
$IDRA Previous Close: $1.56
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of JULIAN BAKER in IDERA PHARMACEUTICALS, INC.
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, GHDX, IDRA, INCY, GEVA, XOMA
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 17 2015 | IDRA | IDERA PHARMACEUTIC ... | BAKER JULIAN | Director | Buy | P | 3.75 | 4,898,409 | 18,369,034 | 6,323,855 | 1.4 M to 6.3 M (+343.64 %) |
| Feb 17 2015 | IDRA | IDERA PHARMACEUTIC ... | BAKER JULIAN | Director | Buy | P | 3.75 | 434,924 | 1,630,965 | 625,495 | 190.6 K to 625.5 K (+228.22 %) |
| Jan 06 2015 | IDRA | IDERA PHARMACEUTIC ... | BAKER JULIAN | Director | Grant | A | 4.90 | 3,927 | 19,242 | 54,128 | 50.2 K to 54.1 K (+7.82 %) |
| Jan 06 2015 | IDRA | IDERA PHARMACEUTIC ... | BAKER JULIAN | Director | Grant | A | 4.90 | 3,927 | 19,242 | 1,425,446 | 1.4 M to 1.4 M (+0.28 %) |
| Jan 06 2015 | IDRA | IDERA PHARMACEUTIC ... | BAKER JULIAN | Director | Grant | A | 4.90 | 3,927 | 19,242 | 190,571 | 186.6 K to 190.6 K (+2.10 %) |
| Oct 03 2014 | IDRA | IDERA PHARMACEUTIC ... | BAKER JULIAN | Director | Grant | A | 2.16 | 8,914 | 19,254 | 50,201 | 41.3 K to 50.2 K (+21.59 %) |
| Oct 03 2014 | IDRA | IDERA PHARMACEUTIC ... | BAKER JULIAN | Director | Grant | A | 2.16 | 8,914 | 19,254 | 1,421,519 | 1.4 M to 1.4 M (+0.63 %) |
| Oct 03 2014 | IDRA | IDERA PHARMACEUTIC ... | BAKER JULIAN | Director | Grant | A | 2.16 | 8,914 | 19,254 | 186,644 | 177.7 K to 186.6 K (+5.02 %) |
| Jul 03 2014 | IDRA | IDERA PHARMACEUTIC ... | BAKER JULIAN | Director | Grant | A | 2.83 | 6,182 | 17,495 | 41,287 | 35.1 K to 41.3 K (+17.61 %) |
| Jul 03 2014 | IDRA | IDERA PHARMACEUTIC ... | BAKER JULIAN | Director | Grant | A | 2.83 | 6,182 | 17,495 | 1,412,605 | 1.4 M to 1.4 M (+0.44 %) |
| Jul 03 2014 | IDRA | IDERA PHARMACEUTIC ... | BAKER JULIAN | Director | Grant | A | 2.83 | 6,182 | 17,495 | 177,730 | 171.5 K to 177.7 K (+3.60 %) |
| Jun 11 2014 | IDRA | IDERA PHARMACEUTIC ... | BAKER JULIAN | Director | Option Exercise | A | 3.25 | 70,000 | 227,500 | 70,000 | |
| Mar 19 2014 | IDRA | IDERA PHARMACEUTIC ... | BAKER JULIAN | Director | Option Exercise | A | 6.06 | 80,000 | 484,800 | 80,000 | |
| Mar 12 2014 | IDRA | IDERA PHARMACEUTIC ... | BAKER JULIAN | Director | Option Exercise | A | 5.82 | 60,000 | 349,200 | 60,000 |
Page: 1